Imprimis Owes Rival Allergan False Ad Drug Profits, Jury Told
Imprimis Pharmaceuticals cost competitor Allergan thousands of prescriptions and millions in profits when it lied to consumers that its eye-treatment drugs used FDA-approved ingredients, a California federal jury heard during closing...To view the full article, register now.
Already a subscriber? Click here to view full article